Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1146P refers to a *pseudogene* corresponding to a variant of U6 small nuclear RNA (snRNA). U6 snRNA is an essential component of the spliceosome, the molecular machinery responsible for excision of introns during pre-mRNA splicing in the nucleus of eukaryotes[1][3]. The RNU6-1146P nomenclature specifically refers to a nonfunctional, likely noncoding, pseudogene copy within the genome that does not code for a functional U6 snRNA molecule. Pseudogenes of U6 are common in vertebrate genomes and do not encode active RNAs or proteins; these duplicated or mutated genomic elements typically lack regulatory, catalytic, or cellular roles[1]. While some pseudogenes elsewhere in the genome can act as regulatory RNAs (such as antisense molecules or decoys), there is no evidence that RNU6-1146P possesses such regulatory function[2]. As a result, RNU6-1146P is not considered a receptor, enzyme, transporter, or therapeutic target and has no documented role in human disease biology or pharmacology. **Notes on correctness:** - This target is a *pseudogene* of U6 snRNA, not a functional coding gene, protein, or therapeutic target. - If you are searching for information on snRNP targets or active spliceosomal RNAs, you should instead refer to canonical U6 snRNA and its associated protein complexes, not this pseudogene. - Most databases and literature will not register RNU6-1146P as a valid biological or drug target, nor associate it with drug-interactions, biomarker roles, or disease relevance[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1146, pseudogene (RNU6-1146P).